The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Carvedilol Market Research Report 2025
Synopsis
Carvedilol (CAS 72956-09-3), C24H26N2O4, the formula weight is 406.47, and its form is white to off-white solid.
The global Carvedilol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Carvedilol is indicated for symptomatic heart failure and for essential hypertension.
This report aims to provide a comprehensive presentation of the global market for Carvedilol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carvedilol.
Report Scope
The Carvedilol market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carvedilol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carvedilol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qilu Pharmaceutical
Roche
Cipla
Ningbo Tianheng Pharmaceutical
Apotex INC
Aurobindo Pharma
BEXIMCO USA
Teva
Mylan
TARO
Sun Pharminds
Zydus Pharms
Lupin
Sandoz
Glenmark Generics
DR Reddy's Labs
Chartwell Molecular
Segment by Type
Tablet
Capsule
Segment by Application
Primary Hypertension
Congestive Heart Failure (CHF)
Left Ventricular Dysfunction
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carvedilol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carvedilol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Carvedilol (CAS 72956-09-3), C24H26N2O4, the formula weight is 406.47, and its form is white to off-white solid.
The global Carvedilol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Carvedilol is indicated for symptomatic heart failure and for essential hypertension.
This report aims to provide a comprehensive presentation of the global market for Carvedilol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carvedilol.
Report Scope
The Carvedilol market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carvedilol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carvedilol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qilu Pharmaceutical
Roche
Cipla
Ningbo Tianheng Pharmaceutical
Apotex INC
Aurobindo Pharma
BEXIMCO USA
Teva
Mylan
TARO
Sun Pharminds
Zydus Pharms
Lupin
Sandoz
Glenmark Generics
DR Reddy's Labs
Chartwell Molecular
Segment by Type
Tablet
Capsule
Segment by Application
Primary Hypertension
Congestive Heart Failure (CHF)
Left Ventricular Dysfunction
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carvedilol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carvedilol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Carvedilol Market Overview
1.1 Product Overview and Scope of Carvedilol
1.2 Carvedilol Segment by Type
1.2.1 Global Carvedilol Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Capsule
1.3 Carvedilol Segment by Application
1.3.1 Global Carvedilol Market Value by Application: (2024-2030)
1.3.2 Primary Hypertension
1.3.3 Congestive Heart Failure (CHF)
1.3.4 Left Ventricular Dysfunction
1.3.5 Other
1.4 Global Carvedilol Market Size Estimates and Forecasts
1.4.1 Global Carvedilol Revenue 2019-2030
1.4.2 Global Carvedilol Sales 2019-2030
1.4.3 Global Carvedilol Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Carvedilol Market Competition by Manufacturers
2.1 Global Carvedilol Sales Market Share by Manufacturers (2019-2024)
2.2 Global Carvedilol Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Carvedilol Average Price by Manufacturers (2019-2024)
2.4 Global Carvedilol Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Carvedilol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Carvedilol, Product Type & Application
2.7 Carvedilol Market Competitive Situation and Trends
2.7.1 Carvedilol Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Carvedilol Players Market Share by Revenue
2.7.3 Global Carvedilol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Carvedilol Retrospective Market Scenario by Region
3.1 Global Carvedilol Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Carvedilol Global Carvedilol Sales by Region: 2019-2030
3.2.1 Global Carvedilol Sales by Region: 2019-2024
3.2.2 Global Carvedilol Sales by Region: 2025-2030
3.3 Global Carvedilol Global Carvedilol Revenue by Region: 2019-2030
3.3.1 Global Carvedilol Revenue by Region: 2019-2024
3.3.2 Global Carvedilol Revenue by Region: 2025-2030
3.4 North America Carvedilol Market Facts & Figures by Country
3.4.1 North America Carvedilol Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Carvedilol Sales by Country (2019-2030)
3.4.3 North America Carvedilol Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Carvedilol Market Facts & Figures by Country
3.5.1 Europe Carvedilol Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Carvedilol Sales by Country (2019-2030)
3.5.3 Europe Carvedilol Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Carvedilol Market Facts & Figures by Country
3.6.1 Asia Pacific Carvedilol Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Carvedilol Sales by Country (2019-2030)
3.6.3 Asia Pacific Carvedilol Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Carvedilol Market Facts & Figures by Country
3.7.1 Latin America Carvedilol Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Carvedilol Sales by Country (2019-2030)
3.7.3 Latin America Carvedilol Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Carvedilol Market Facts & Figures by Country
3.8.1 Middle East and Africa Carvedilol Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Carvedilol Sales by Country (2019-2030)
3.8.3 Middle East and Africa Carvedilol Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Carvedilol Sales by Type (2019-2030)
4.1.1 Global Carvedilol Sales by Type (2019-2024)
4.1.2 Global Carvedilol Sales by Type (2025-2030)
4.1.3 Global Carvedilol Sales Market Share by Type (2019-2030)
4.2 Global Carvedilol Revenue by Type (2019-2030)
4.2.1 Global Carvedilol Revenue by Type (2019-2024)
4.2.2 Global Carvedilol Revenue by Type (2025-2030)
4.2.3 Global Carvedilol Revenue Market Share by Type (2019-2030)
4.3 Global Carvedilol Price by Type (2019-2030)
5 Segment by Application
5.1 Global Carvedilol Sales by Application (2019-2030)
5.1.1 Global Carvedilol Sales by Application (2019-2024)
5.1.2 Global Carvedilol Sales by Application (2025-2030)
5.1.3 Global Carvedilol Sales Market Share by Application (2019-2030)
5.2 Global Carvedilol Revenue by Application (2019-2030)
5.2.1 Global Carvedilol Revenue by Application (2019-2024)
5.2.2 Global Carvedilol Revenue by Application (2025-2030)
5.2.3 Global Carvedilol Revenue Market Share by Application (2019-2030)
5.3 Global Carvedilol Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Qilu Pharmaceutical
6.1.1 Qilu Pharmaceutical Corporation Information
6.1.2 Qilu Pharmaceutical Description and Business Overview
6.1.3 Qilu Pharmaceutical Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Qilu Pharmaceutical Carvedilol Product Portfolio
6.1.5 Qilu Pharmaceutical Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Carvedilol Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Cipla
6.3.1 Cipla Corporation Information
6.3.2 Cipla Description and Business Overview
6.3.3 Cipla Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cipla Carvedilol Product Portfolio
6.3.5 Cipla Recent Developments/Updates
6.4 Ningbo Tianheng Pharmaceutical
6.4.1 Ningbo Tianheng Pharmaceutical Corporation Information
6.4.2 Ningbo Tianheng Pharmaceutical Description and Business Overview
6.4.3 Ningbo Tianheng Pharmaceutical Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ningbo Tianheng Pharmaceutical Carvedilol Product Portfolio
6.4.5 Ningbo Tianheng Pharmaceutical Recent Developments/Updates
6.5 Apotex INC
6.5.1 Apotex INC Corporation Information
6.5.2 Apotex INC Description and Business Overview
6.5.3 Apotex INC Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Apotex INC Carvedilol Product Portfolio
6.5.5 Apotex INC Recent Developments/Updates
6.6 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aurobindo Pharma Carvedilol Product Portfolio
6.6.5 Aurobindo Pharma Recent Developments/Updates
6.7 BEXIMCO USA
6.6.1 BEXIMCO USA Corporation Information
6.6.2 BEXIMCO USA Description and Business Overview
6.6.3 BEXIMCO USA Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BEXIMCO USA Carvedilol Product Portfolio
6.7.5 BEXIMCO USA Recent Developments/Updates
6.8 Teva
6.8.1 Teva Corporation Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Carvedilol Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Carvedilol Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 TARO
6.10.1 TARO Corporation Information
6.10.2 TARO Description and Business Overview
6.10.3 TARO Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.10.4 TARO Carvedilol Product Portfolio
6.10.5 TARO Recent Developments/Updates
6.11 Sun Pharminds
6.11.1 Sun Pharminds Corporation Information
6.11.2 Sun Pharminds Carvedilol Description and Business Overview
6.11.3 Sun Pharminds Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Pharminds Carvedilol Product Portfolio
6.11.5 Sun Pharminds Recent Developments/Updates
6.12 Zydus Pharms
6.12.1 Zydus Pharms Corporation Information
6.12.2 Zydus Pharms Carvedilol Description and Business Overview
6.12.3 Zydus Pharms Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zydus Pharms Carvedilol Product Portfolio
6.12.5 Zydus Pharms Recent Developments/Updates
6.13 Lupin
6.13.1 Lupin Corporation Information
6.13.2 Lupin Carvedilol Description and Business Overview
6.13.3 Lupin Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lupin Carvedilol Product Portfolio
6.13.5 Lupin Recent Developments/Updates
6.14 Sandoz
6.14.1 Sandoz Corporation Information
6.14.2 Sandoz Carvedilol Description and Business Overview
6.14.3 Sandoz Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sandoz Carvedilol Product Portfolio
6.14.5 Sandoz Recent Developments/Updates
6.15 Glenmark Generics
6.15.1 Glenmark Generics Corporation Information
6.15.2 Glenmark Generics Carvedilol Description and Business Overview
6.15.3 Glenmark Generics Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Glenmark Generics Carvedilol Product Portfolio
6.15.5 Glenmark Generics Recent Developments/Updates
6.16 DR Reddy's Labs
6.16.1 DR Reddy's Labs Corporation Information
6.16.2 DR Reddy's Labs Carvedilol Description and Business Overview
6.16.3 DR Reddy's Labs Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.16.4 DR Reddy's Labs Carvedilol Product Portfolio
6.16.5 DR Reddy's Labs Recent Developments/Updates
6.17 Chartwell Molecular
6.17.1 Chartwell Molecular Corporation Information
6.17.2 Chartwell Molecular Carvedilol Description and Business Overview
6.17.3 Chartwell Molecular Carvedilol Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Chartwell Molecular Carvedilol Product Portfolio
6.17.5 Chartwell Molecular Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Carvedilol Industry Chain Analysis
7.2 Carvedilol Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Carvedilol Production Mode & Process
7.4 Carvedilol Sales and Marketing
7.4.1 Carvedilol Sales Channels
7.4.2 Carvedilol Distributors
7.5 Carvedilol Customers
8 Carvedilol Market Dynamics
8.1 Carvedilol Industry Trends
8.2 Carvedilol Market Drivers
8.3 Carvedilol Market Challenges
8.4 Carvedilol Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
